Searched for
EPIRUS BIOPHARMACEUTICALS
Reliance Life gains global rights for copies of InfliximabFor Infliximab, Reliance Life Sciences had completed process development, manufacturing, clinical trials in India and obtained marketing ap...- Reliance Life Sciences ends deal with Epirus for Remicade copiesJanssen’s Remicade is the third biggest pharmaceutical brand globally with sales exceeding $8 billion last year.
- Sun Pharma’s US arm Taro buys Zalicus Pharmaceuticals of CanadaTaro has acquired Canada’s Zalicus, a company engaged in the development of a pain management drug candidate coded Z944.
- How Dr Reddy’s is rebooting its biosimilars playDr Reddy’s was among the first to race off the blocks with four launches in India about as many years. But things have slowed since.
- Ranbaxy launches arthritis drug Infimab in IndiaInfimab has been introduced in the Indian market through a licensing partnership with Epirus Biopharmaceuticals, Ranbaxy said in a statemen...
- Ranbaxy enters into licensing pact with EPIRUS SwitzerlandRanbaxy Laboratories have entered into a licensing pact with EPIRUS Switzerland GmbH for treating rheumatoid arthiritis.
Load More